Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
A synbiotic formulation of Lactobacillus reuteri and inulin alleviates ASD-like behaviors in a mouse model: the mediating role of the gutbrain axis
Contributing author: Martin Schain, PET Imaging Director @ Antaros Medical While the concept of incretins has been around for a while, interest has grown significantly in recent years with the demonstrated efficacy and regulatory approvals of incretin-based therapies for the treatment of both diabetes and obesity
Combat side effects by eating right More than 70 percent of adults over age 18 have tried to lose weight, including 83 percent of women age 50-plus, according to a November 2024 AARP poll of more than 3,500 U.S
67 The histological morphology of the acquired melanocytic nevi largely dictates the method of removal
US$ 29.58
US$ 28.04
US$ 29.17
